NTR

Navigating Potential Headwinds for Nutrien Stock

This afternoon we watched Nutrien drop -1.6% to a price of $45.74 per share. The Large-Cap Agricultural Inputs company is now trading -26.6% below its average target price of $62.32. Analysts have set target prices ranging from $48.0 to $75.0 per share for Nutrien, and have given the stock an average rating of buy.

The stock has a very low short interest at 0.6%, and a short ratio of 1.64. At 0.03%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that an average number of institutional investors are invested in the stock, with 70.1% of Nutrien's shares being owned by this investor type.

Institutions Invested in Nutrien

Date Reported Holder Percentage Shares Value
2024-03-31 Royal Bank of Canada 6% 29,088,438 $1,330,505,202
2024-06-30 Vanguard Group Inc 4% 19,112,283 $874,195,856
2024-03-31 Mackenzie Financial Corporation 3% 13,854,197 $633,690,994
2024-06-30 Dodge & Cox Inc 2% 12,199,059 $557,984,979
2024-03-31 Bank of Montreal/Can/ 2% 11,560,052 $528,756,797
2024-06-30 FMR, LLC 2% 10,647,263 $487,005,827
2024-03-31 Deutsche Bank Aktiengesellschaft 2% 10,167,099 $465,043,125
2024-06-30 First Eagle Investment Management, LLC 2% 9,477,248 $433,489,339
2024-06-30 1832 Asset Management L.P. 2% 9,006,528 $411,958,605
2024-03-31 Manufacturers Life Insurance Co. 1% 7,253,769 $331,787,406

Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Nutrien.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS